Acetaminophen Child Strawberry Oral Suspension Recalled for Contaminated Excipient
Target-distributed Acetaminophen Child Strawberry Oral Suspension (160 mg/5 ml) is being recalled because it was manufactured with a contaminated excipient that was itself recalled from the supplier.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a manufacturing deviation (use of contaminated excipient). The source text does not report any illnesses, injuries, or hospitalizations, and the hazard is manufacturing-process-related rather than a known direct safety threat. Per the rubric, Class II recalls without reported illness are typically scored as 2 (Moderate).
Plain-English summary
Perrigo Company PLC is recalling Acetaminophen Child Strawberry Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) bottles distributed by Target Corporation nationwide. The product has NDC 11673-759-26 and affected batch codes are 1FK1252, 1GK0905, with expiration date 01/31/2023.
The recall was initiated because the products were manufactured using a contaminated excipient (an inactive ingredient) that had itself been recalled by the excipient supplier. This represents a deviation from current Good Manufacturing Practice (CGMP) standards.
Consumers who have purchased this product should consult their pharmacist or healthcare provider for guidance. This is a Class II recall.
The recalled product
- Product
- Acetaminophen Child Strawberry Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) per bottle, Distributed by Target Corporation, Minneapolis, MN 55403. NDC: 11673-759-26
- Manufacturer
- Perrigo Company PLC
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Batch: 1FK1252
- 1GK0905
- Exp 01/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27